Cantor Fitzgerald Reiterates Overweight Rating on Cartesian Therapeutics (RNAC)

Go back to Cantor Fitzgerald Reiterates Overweight Rating on Cartesian Therapeutics (RNAC)
(NASDAQ: RNAC) Delayed: 8.43 --0 (-0%)
Previous Close $8.43    52 Week High
Open $8.43    52 Week Low
Day High $8.43    P/E N/A 
Day Low $8.43    EPS
Volume 14,976